Apellis Pharmaceuticals
Why Robinhood?
You can watch APLS and buy or sell other stocks, ETFs, and their options commission-free!About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
The current Apellis Pharmaceuticals(APLS) stock price is $41.03, with a market capitalization of 5.25B. The stock trades at a price-to-earnings (P/E) ratio of 41.01.
On 2026-08-25, Apellis Pharmaceuticals(APLS) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Apellis Pharmaceuticals(APLS) stock has reached 0, versus its average volume of 8.56M.
Over the past 52 weeks, Apellis Pharmaceuticals(APLS) stock has traded between a high of $41.14 and a low of $16.61.
Over the past 52 weeks, Apellis Pharmaceuticals(APLS) stock has traded between a high of $41.14 and a low of $16.61.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.